Systemic Inflammation and COPD: The Framingham Heart Study
- 31 January 2008
- journal article
- Published by Elsevier BV in Chest
- Vol. 133 (1), 19-25
- https://doi.org/10.1378/chest.07-0058
Abstract
The current paradigm for the pathogenesis of COPD includes an ultimately maladaptive local inflammatory response to environmental stimuli. We examined the hypothesis that systemic inflammatory biomarkers are associated with impaired lung function, particularly among those with extensive cigarette smoking. Using data from the Framingham Heart Study, we examined cross-sectional associations of systemic inflammatory biomarkers (CD40 ligand [CD40L], intercellular adhesion molecule [ICAM]-1, interleukin [IL]-6, monocyte chemoattractant protein-1, P-selectin, and myeloperoxidase, in addition to C-reactive protein) to impaired lung function. IL-6 was consistently associated with impaired lung function; a 1-SD higher concentration of IL-6 was associated with a 41-mL lower FEV(1) (95% confidence interval [CI], - 61 to - 20) and a borderline 15% higher odds of COPD (odds ratio, 1.15; 95% CI, 0.99 to 1.34). Additionally, P-selectin was associated with lower FEV(1) levels; after adjusting for the other biomarkers, a 1-SD higher concentration of P-selectin predicted an FEV(1) that was on average 19 mL lower (95% CI, - 37 to 0). Including the biomarkers individually as sole exposures in the models generally strengthened the impaired lung function/biomarker association; the relations of ICAM-1 to FEV(1), and ICAM and CD40L to COPD became significant. The observed associations did not vary significantly with smoking history, except that the association between CD40L and COPD appeared greater in individuals with more extensive smoking histories. Among participants in the Framingham Heart Study, systemic inflammation was associated with lower levels of pulmonary function. Further research into the role of systemic inflammation in the development of pulmonary dysfunction is merited.This publication has 30 references indexed in Scilit:
- Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein LevelCirculation, 2006
- Association of Educational Level with Inflammatory Markers in the Framingham Offspring StudyAmerican Journal of Epidemiology, 2006
- Pathogenesis of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: Evidence for susceptibility loci on 1qAtherosclerosis, 2005
- Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys)European Journal of Pharmacology, 2004
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax, 2004
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Long-term Repeatability of Induced Sputum Cells and Inflammatory Markers in Stable, Moderately Severe COPDChest, 2003
- Associations between Lung Function and Estimated Average Exposure to NO2 in Eight Areas of SwitzerlandEpidemiology, 1998
- Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140).JCI Insight, 1992